Prem Pavoor
About Prem Pavoor
Data last updated:
Prem Pavoor has 14 years in corporate governance. Holds Director and Nominee Director roles. Currently with 8 companies, including Richcore Enzymes Private Limited and Immuneel Therapeutics Private Limited. Formerly with 12 companies, such as Ashish Life Science Private Limited and Milk Mantra Dairy Private Limited. Engaged in General Business, Technology and more. The 8 current companies with reported revenue have a combined latest revenue of ₹5,966 Cr; the largest is Alpha Alternatives Msar Llp at ₹4,486 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alpha Alternatives Msar Llp AAW-2814 | Partner | 02 Mar 2022 | 2021 | ₹4,486 Cr (FY 2025) | Active |
 Enzene Biosciences Limited U24232PN2006PLC165610 | Director | 30 Jan 2023 | 2006 | ₹385 Cr (FY 2025) | Active |
 Caplin Steriles Limited U24304TN2018PLC126270 | Nominee Director | 07 Mar 2019 | 2018 | ₹377 Cr (FY 2025) | Active |
 Laurus Bio Private Limited U02423KA2005PTC036770 | Director | 20 Dec 2024 | 2005 | ₹203 Cr (FY 2026) | Active |
| Makeo Healthcare Technologies Private Limited U85310MH2017PTC294169 | Nominee Director | 07 Aug 2021 | 2017 | ₹183 Cr (FY 2024) | Active |
 Eight Roads Investment Advisors Private Limited U74140MH2007PTC172259 | Whole-Time Director | 06 Apr 2018 | 2007 | ₹168 Cr (FY 2025) | Active |
 Plasmagen Biosciences Private Limited U51909KA2010PTC055077 | Director | 28 Jul 2017 | 2010 | ₹162 Cr (FY 2025) | Active |
 Immuneel Therapeutics Private Limited U24230KA2018PTC119691 | Director | 20 Apr 2022 | 2018 | ₹2.25 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ashish Life Science Private Limited U24100MH1992PTC064810 | Director | 06 Feb 2019 | 1992 | ₹215 Cr (FY 2025) | Active |
 Milk Mantra Dairy Private Limited U15202OR2009PTC027213 | Director | 21 Feb 2017 | 2009 | ₹279 Cr (FY 2024) | Active |
 Medwell Ventures Private Limited U85100DL2014PTC429322 | Nominee Director | 27 May 2015 | 2014 | ₹73.62 Cr (FY 2023) | Active |
 Laurus Labs Limited L24239AP2005PLC047518 | Alternate Director | 03 Dec 2012 | 2005 | ₹6,868 Cr (FY 2026) | Active |
 Xcyton Diagnostics Private Limited U33112KA1993PTC014776 | Alternate Director | 31 Aug 2012 | 1993 | ₹1.59 Cr (FY 2025) | Active |
 Kiran Medical Systems Limited U33111TN1974PLC095942 | Director | 02 Nov 2012 | 1974 | – | Amalgamated |
 Api Holdings Limited U60100MH2019PLC323444 | Director | 27 Aug 2020 | 2019 | ₹6,689 Cr (FY 2026) | Active |
 Trivitron Healthcare Private Limited U85110TN1998PTC040515 | Nominee Director | 29 Sep 2015 | 1998 | ₹497 Cr (FY 2024) | Active |
| Richcore Enzymes Private Limited U24100KA2012PTC067211 | Director | 22 Feb 2013 | 2012 | ₹1.98 Cr (FY 2015) | Amalgamated |
 91Streets Media Technologies Private Limited U74999MH2014PTC259739 | Additional Director | 19 Mar 2020 | 2014 | ₹364 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prem Pavoor
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prem Pavoor
Prem Pavoor has 14 years in corporate governance. Holds Director and Nominee Director roles. Currently with 8 companies, including Richcore Enzymes Private Limited and Immuneel Therapeutics Private Limited. Formerly with 12 companies, such as Ashish Life Science Private Limited and Milk Mantra Dairy Private Limited. Engaged in General Business, Technology and more. The 8 current companies with reported revenue have a combined latest revenue of ₹5,966 Cr; the largest is Alpha Alternatives Msar Llp at ₹4,486 Cr (FY 2025).
Prem Pavoor is associated with 8 companies as Director and Nominee Director, including Alpha Alternatives Msar Llp (₹4,486 Cr), Enzene Biosciences Limited (₹385 Cr), Caplin Steriles Limited (₹377 Cr).
Prem Pavoor has expertise in General Business, Technology and other sectors.
Prem Pavoor has 14 years in corporate governance.
By reported revenue, the largest current company of Prem Pavoor is Alpha Alternatives Msar Llp, with revenue of ₹4,486 Cr (FY 2025).
The 8 current companies of Prem Pavoor that report revenue have a combined latest revenue of ₹5,966 Cr.
Prem Pavoor currently holds positions at 8 companies; the 5 largest by reported revenue are Alpha Alternatives Msar Llp (₹4,486 Cr), Enzene Biosciences Limited (₹385 Cr), Caplin Steriles Limited (₹377 Cr), Laurus Bio Private Limited (₹203 Cr), Makeo Healthcare Technologies Private Limited (₹183 Cr).